GLAXOSMITHKLINE PHARMACEUTICALS
Quarterly Results Analysis [Dec2024]
GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹949 Cr | ₹1,011 Cr | ₹815 Cr | ₹930 Cr | ₹805 Cr | ₹957 Cr | ₹762 Cr | ₹787 Cr |
Expenses | ₹658 Cr | ₹689 Cr | ₹584 Cr | ₹673 Cr | ₹587 Cr | ₹668 Cr | ₹618 Cr | ₹618 Cr |
Operating Income | ₹292 Cr | ₹322 Cr | ₹231 Cr | ₹257 Cr | ₹218 Cr | ₹289 Cr | ₹144 Cr | ₹170 Cr |
Other Income | ₹35 Cr | ₹35 Cr | ₹36 Cr | ₹30 Cr | ₹28 Cr | ₹28 Cr | ₹36 Cr | ₹28 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
Depreciation | ₹19 Cr | ₹17 Cr | ₹16 Cr | ₹18 Cr | ₹17 Cr | ₹18 Cr | ₹16 Cr | ₹17 Cr |
Profit Before Tax | ₹308 Cr | ₹344 Cr | ₹249 Cr | ₹271 Cr | ₹65 Cr | ₹299 Cr | ₹181 Cr | ₹190 Cr |
Profit After Tax | ₹230 Cr | ₹253 Cr | ₹182 Cr | ₹194 Cr | ₹46 Cr | ₹218 Cr | ₹132 Cr | ₹133 Cr |
EPS | ₹13.57 | ₹14.90 | ₹10.76 | ₹11.48 | ₹2.70 | ₹12.84 | ₹7.81 | ₹7.88 |
Industry Peers & Returns | 1W | 1M | 1Y |
GLAXOSMITHKLINE PHARMACEUTICALS | -3.8% | 2.6% | 35% |
SUN PHARMACEUTICAL INDUSTRIES | -2.7% | 3.9% | 19.8% |
DIVIS LABORATORIES | 1% | 8.5% | 55.3% |
CIPLA | -2.6% | 3.9% | 6.4% |
TORRENT PHARMACEUTICALS | -0.7% | 2.5% | 22.3% |
DR REDDYS LABORATORIES | -1.9% | 0.9% | -7.8% |
MANKIND PHARMA | -1.4% | 0.4% | 1.4% |
ZYDUS LIFESCIENCES | -0.1% | -0.5% | -10.9% |
LUPIN | -1.1% | 3.1% | 24.4% |
GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -6.07 % |
Y-o-Y | 17.90 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹949 Cr | -6.07 | |
Sep2024 | ₹1,011 Cr | 24.07 | |
Jun2024 | ₹815 Cr | -12.38 | |
Mar2024 | ₹930 Cr | 15.47 | |
Dec2023 | ₹805 Cr | -15.85 | |
Sep2023 | ₹957 Cr | 25.65 | |
Jun2023 | ₹762 Cr | -3.28 | |
Mar2023 | ₹787 Cr | - |
GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -9.26 % |
Y-o-Y | 33.87 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹292 Cr | -9.26 | |
Sep2024 | ₹322 Cr | 39.55 | |
Jun2024 | ₹231 Cr | -10.39 | |
Mar2024 | ₹257 Cr | 17.98 | |
Dec2023 | ₹218 Cr | -24.67 | |
Sep2023 | ₹289 Cr | 101.20 | |
Jun2023 | ₹144 Cr | -15.24 | |
Mar2023 | ₹170 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -3.39 % |
Y-o-Y | 13.55 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 30.75% | -3.39 | |
Sep2024 | 31.83% | 12.47 | |
Jun2024 | 28.3% | 2.28 | |
Mar2024 | 27.67% | 2.18 | |
Dec2023 | 27.08% | -10.48 | |
Sep2023 | 30.25% | 60.14 | |
Jun2023 | 18.89% | -12.38 | |
Mar2023 | 21.56% | - |
GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -8.96 % |
Y-o-Y | 402.80 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹230 Cr | -8.96 | |
Sep2024 | ₹253 Cr | 38.49 | |
Jun2024 | ₹182 Cr | -6.25 | |
Mar2024 | ₹194 Cr | 325.37 | |
Dec2023 | ₹46 Cr | -78.98 | |
Sep2023 | ₹218 Cr | 64.47 | |
Jun2023 | ₹132 Cr | -0.88 | |
Mar2023 | ₹133 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -3.08 % |
Y-o-Y | 326.23 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 24.21 % | -3.08 | |
Sep2024 | 24.98 % | 11.62 | |
Jun2024 | 22.38 % | 6.98 | |
Mar2024 | 20.92 % | 268.31 | |
Dec2023 | 5.68 % | -75.01 | |
Sep2023 | 22.73 % | 30.93 | |
Jun2023 | 17.36 % | 2.48 | |
Mar2023 | 16.94 % | - |
GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -8.93 % |
Y-o-Y | 402.59 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹13.57 | -8.93 | |
Sep2024 | ₹14.9 | 38.48 | |
Jun2024 | ₹10.76 | -6.27 | |
Mar2024 | ₹11.48 | 325.19 | |
Dec2023 | ₹2.7 | -78.97 | |
Sep2023 | ₹12.84 | 64.40 | |
Jun2023 | ₹7.81 | -0.89 | |
Mar2023 | ₹7.88 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD